The use of psychotropic medication during pregnancy: how about the newborn?
about
Pharmacotherapy of obsessive-compulsive disorder during pregnancy: a clinical approachAntidepressants, anxiolytics, and hypnotics in pregnancy and lactationNeonatal Adaptation Issues After Maternal Exposure to Prescription Drugs: Withdrawal Syndromes and Residual Pharmacological Effects.The multifaceted question of the prescription of antidepressants during pregnancy.Use of antidepressants during pregnancy in the Netherlands: observational study into postpartum interventions.Maternal exposure to carbamazepine at environmental concentrations can cross intestinal and placental barriers.Bioanalysis during pregnancy: recent advances and novel sampling strategies.Risk-benefit balance assessment of SSRI antidepressant use during pregnancy and lactation based on best available evidence.A pharmacological approach to panic disorder during pregnancy.Prenatal depression screening and antidepressant prescription: obstetrician-gynecologists' practices, opinions, and interpretation of evidence.Depression and Anxiety During Pregnancy: Evaluating the Literature in Support of Clinical Risk-Benefit Decision-Making.Newborn Brain Function Is Affected by Fetal Exposure to Maternal Serotonin Reuptake Inhibitors.Risk factors for poor neonatal adaptation after exposure to antidepressants in utero.Serotonin reuptake inhibitors in pregnancy: can genes help us in predicting neonatal adverse outcome?Adapted Finnegan scoring list for observation of anti-depressant exposed infants.Failure to thrive potentially secondary to maternal venlafaxine use.Interest of the trajectory method for the evaluation of outcomes after in utero drug exposure: example of anxiolytics and hypnotics.Poor neonatal adaptation following in-utero exposure to quetiapine and lamotrigine.Chronic use of psychotropic medications in breastfeeding women: Is it safe?
P2860
Q26774013-DEC53CFD-A824-4C0C-A567-4983DFDAF650Q26795384-D7A1CB89-9B7E-41DB-84C2-2F253FB28A34Q30249670-7A2A240C-399F-4FFC-B318-82EC5D40F679Q33744543-D4FD6A19-FF71-41B2-8BA9-2F219BA4D1BAQ36246581-C27A6763-641E-48E2-9DD2-3629775151D6Q36964234-05690684-2E8A-4C72-9C8D-E512ACF01E99Q38296225-C7BF6324-4B2E-435C-A605-5ED6CA76D0F9Q38305749-68A1D2C4-7784-45CA-B110-D1FE36B097E0Q38516009-CB19CBFB-6A47-45F0-B26C-563F729D3A4EQ38645257-1764C6F0-C37F-419A-96F9-A5EDED08B00AQ38811512-CF2CF30F-A674-447A-A2B7-59F720AC546AQ38857229-50C4B1C3-1E28-46B8-AC96-47CC05FF79DCQ41624880-52DFBFB5-59C1-4DC0-8EF8-C22B0066D343Q41912767-C6A6E692-EF39-4E42-989E-545285620241Q44056145-7C809426-8389-4095-B8CE-3F49DC665219Q47587045-AD1C39F5-DC0A-4B9D-BF24-5890E219A934Q47940100-B0FE08FC-3B7D-4C2F-96C1-8CD7AE5C8FAAQ48348797-CC227850-B01A-41EB-8300-D5CA892ADE38Q55000814-9BB51871-9ED2-4B22-8327-2A279CB4F4EF
P2860
The use of psychotropic medication during pregnancy: how about the newborn?
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
The use of psychotropic medication during pregnancy: how about the newborn?
@ast
The use of psychotropic medication during pregnancy: how about the newborn?
@en
The use of psychotropic medication during pregnancy: how about the newborn?
@nl
type
label
The use of psychotropic medication during pregnancy: how about the newborn?
@ast
The use of psychotropic medication during pregnancy: how about the newborn?
@en
The use of psychotropic medication during pregnancy: how about the newborn?
@nl
prefLabel
The use of psychotropic medication during pregnancy: how about the newborn?
@ast
The use of psychotropic medication during pregnancy: how about the newborn?
@en
The use of psychotropic medication during pregnancy: how about the newborn?
@nl
P2093
P2860
P356
P1476
The use of psychotropic medication during pregnancy: how about the newborn?
@en
P2093
Adriaan Honig
Koert M Dolman
Noera Kieviet
P2860
P304
P356
10.2147/NDT.S36394
P407
P577
2013-01-01T00:00:00Z